Skip to main content

Table 2 From which disease stage do neurologists start to pay attention to the non-motor symptoms associated with Parkinson’s disease

From: Managing non-motor symptoms of Parkinson disease in China: clinical perspectives

Item

Total

Specialty

Had or had not read guideline

 

(n = 854)

Movement disorder specialists (n = 259)

General neurologists

(n = 595)

p value

Read

(n = 693)

not read

(n = 161)

p value

All non-motor symptoms

 Prodromal + Early, n(%)

662 (77.5)

231(89.2)

431(80.0)

 

562(81.1)

100(62.1)

< 0.0001

 Middle + Late + unfollowed, n(%)

192(22.5)

28(10.8)

164(20.0)

< 0.0001

131(18.9)

61(37.9)

Depression/anxiety

 Prodromal + Early, n(%)

561(65.7)

195(72.3)

366(61.5)

 

482(56.4)

79(49.1)

0.1004

 Middle + Late + unfollowed, n(%)

293(34.3)

64(24.7)

229(38.5)

< 0.0001

372(43.6)

82(50.9)

Cognitive impairment/dementia

 Prodromal + Early, n(%)

268(31.4)

85(32.8)

183(30.8)

 

235(33.9)

33(20.5)

0.0009

 Middle + Late + unfollowed, n(%)

586(68.6)

174(67.2)

412(69.2)

0.5747

458(66.1)

128(79.5)

Psychotic symptoms

 Prodromal + Early, n(%)

212(24.8)

64(24.7)

148(24.9)

 

180(26.0)

32(74.0)

0.1284

 Middle + Late + unfollowed, n(%)

642(75.2)

195(75.3)

447(75.1)

> 0.9999

513(20.0)

129(80.0)